For the modern American healthcare consumer, the most daunting challenge is often not the medical procedure itself, but the financial ambiguity that precedes it. While national discourse frequently centers on the rising costs of premiums and prescription drugs, a more insidious factor—the paralyzing uncertainty regarding out-of-pocket expenses—is increasingly recognized as a primary driver of care […]
SK Biopharmaceuticals, a prominent South Korean pharmaceutical company with a growing commercial footprint in the United States, has finalized a definitive agreement to in-license opakalim, a late-stage epilepsy drug candidate from Biohaven. The deal, valued at up to $795 million including upfront payments and potential milestones, represents a significant move for the Seoul-based drugmaker as […]
The rapid proliferation of artificial intelligence across the United States healthcare sector has reached a critical juncture where the speed of deployment is significantly outstripping the development of necessary oversight frameworks. Recent findings from a comprehensive study conducted by UPMC’s Center for Connected Medicine (CCM) and KLAS Research reveal a stark disconnect between the industry’s […]
The United States healthcare landscape is approaching a significant inflection point as the provisions of H.R. 1, the federal budget reconciliation law, move toward implementation. As hospital leadership teams across the nation are briefed on the upcoming structural changes, a pervasive sense of cautious observation has taken hold. While many institutions are awaiting further guidance […]
The field of psychiatry is currently undergoing a significant paradigm shift as clinicians and researchers increasingly recognize the inextricable link between the brain’s function and the body’s metabolic systems. For decades, the medical establishment has largely treated psychiatric disorders as isolated neurological or chemical imbalances, focusing almost exclusively on neurotransmitters and psychological interventions. However, a […]
The modern healthcare Chief Financial Officer’s inbox has become a focal point for the aggressive marketing of artificial intelligence in Revenue Cycle Management (RCM). These pitches often follow a standardized script: the promise of lower denial rates, accelerated collections, and a significant reduction in overhead costs. However, while the sales narratives remain consistent, the depth […]
The promise of medical technology often evaporates at the point of clinical delivery, not because of the quality of the hardware or software, but due to a fundamental disconnect between institutional strategy and operational reality. A recent case study involving augmented-reality (AR) captioning glasses serves as a stark illustration of this phenomenon. A med-tech vendor […]
The landscape of healthcare investment is undergoing a seismic shift as artificial intelligence (AI) transitions from a supportive administrative tool to a core clinical necessity. According to the 17th Healthcare Investments and Exits report released by Silicon Valley Bank, AI-driven initiatives accounted for nearly half of all healthcare investment activity entering 2025. This surge in […]
The U.S. Food and Drug Administration (FDA) has granted approval to Lisraya (brepocitinib), a once-daily oral medication for the treatment of dermatomyositis in adults, signaling a transformative shift in the management of this rare and debilitating autoimmune condition. Developed by Priovant Therapeutics, a subsidiary of Roivant Sciences, Lisraya becomes the first drug specifically engineered to […]
A coordinated and highly sophisticated phishing campaign is currently targeting patients across more than a dozen major U.S. health systems, leveraging the brand recognition of Epic Systems’ MyChart patient portal to steal sensitive personal, medical, and financial information. The fraudulent operation, which has prompted widespread warnings from healthcare providers this week, utilizes deceptive emails and […]
